The 56-week OSTRO trial evaluated the efficacy and safety of benralizumab, an interleukin-5 antagonist, in 413 adult patients with severe nasal polyposis. Treatment with benralizumab was associated ...

Benralizumab (Fasenra) significantly reduced nasal polyp score (NPS) and average nasal blockage score (NBS) compared with placebo for patients with severe chronic rhinosinusitis with nasal polyps ...

Competition among biologics that target inflammatory respiratory disease is heating up even further. On Thursday, AstraZeneca said its Fasenra, used in tandem with standard steroids, significantly ...

Nasal polyps are noncancerous growths that can form in the nasal cavity. Although benign, they can have a significant impact on a person’s quality of life. Nasal polyps often occur along with ...

SUNNYVALE, Calif.--(BUSINESS WIRE)--Aerin Medical Inc., a company that provides Ear, Nose and Throat (ENT) physicians with non-invasive solutions to treat chronic nasal conditions, today announced ...

Surgery was more effective than medical management for patients with nasal obstruction associated with septal deviation, the multicenter NAIROS trial found. Patient-reported Sino-Nasal Outcome Test-22 ...

You may develop nasal polyps when your nasal passages or sinuses are constantly irritated and swollen. These soft, noncancerous growths can be found in nasal passages and sinuses and form from the ...